Riparian

Two Labs, an Envision Pharma Group company acquires Riparian

The partnership expands Two Labs’ suite of services and broadens its integration competency to include government price reporting London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in global healthcare, acknowledges the announcement from its portfolio company, Envision Pharma Group, regarding the acquisition of Riparian by Two Labs.… read more

Subscribe to our email alerts

Email updates